Uric acid lowering therapies (UAR) showed no clear difference in dialysis at 2 years compared with placebo, no treatment or usual care (low certainty).

1 finding from 1 review

Uric acid lowering therapies for preventing or delaying the progression of chronic kidney disease 2017 · Cochrane Headline outcomes only
RR 0.4 [0.05, 3]
2 studies · 220 participants
Low

Uric acid lowering therapies (UAR) vs Placebo, no intervention or usual care (with or without placebo)

Creatinine level · people with CKD

1 finding from 1 review

Uric acid lowering therapies for preventing or delaying the progression of chronic kidney disease 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 83 participants
Low

Uric acid lowering therapies (UAR) vs Placebo, no intervention or usual care (with or without placebo)

eGFR or creatinine clearance (mL/min/1.73m²) · people with CKD

1 finding from 1 review

Uric acid lowering therapies for preventing or delaying the progression of chronic kidney disease 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 164 participants
Moderate

Uric acid lowering therapies (UAR) vs Placebo, no intervention or usual care (with or without placebo)

Cardiovascular events · people with CKD

Uric acid lowering therapies (UAR) showed no clear difference in cardiovascular events compared with placebo, no treatment or usual care (low certainty).

1 finding from 1 review

Uric acid lowering therapies for preventing or delaying the progression of chronic kidney disease 2017 · Cochrane Headline outcomes only
RR 0.46 [0.2, 1.04]
1 study · 113 participants
Low